Showing results (611-620 of 26,310) with videos related to
Sort By:
Pageof 2,631
Bioorganic & Medicinal Chemistry Letters|May 17, 2003
Density functional theory calculations for resveratrolHuai Cao, Xulin Pan, Cong Li, et al.Bioorganic & Medicinal Chemistry Letters|May 17, 2003
Optimization of alpha-acylaminoketone ecdysone agonists for control of gene expressionColin M Tice, Robert E Hormann, Christine S Thompson, et al.Bioorganic & Medicinal Chemistry Letters|May 17, 2003
Tetrahydroquinoline-based selective estrogen receptor modulators (SERMs)Owen B Wallace, Kenneth S Lauwers, Scott A Jones, et al.Bioorganic & Medicinal Chemistry Letters|May 17, 2003
Redefining the structure-activity relationships of 2,6-methano-3-benzazocines. Part 2: 8-formamidocyclazocine analoguesMark P Wentland, Xufeng Sun, Yingchun Ye, et al.Bioorganic & Medicinal Chemistry Letters|May 17, 2003
Novel pyrrolyllactone and pyrrolyllactam indolinones as potent cyclin-dependent kinase 2 inhibitorsXiaoyuan Li, Ping Huang, Jingrong Jean Cui, et al.Bioorganic & Medicinal Chemistry Letters|October 26, 2001
Discovery of selective hydroxamic acid inhibitors of tumor necrosis factor-alpha converting enzymeJ Holms, K Mast, P Marcotte, et al.Bioorganic & Medicinal Chemistry Letters|October 26, 2001
SELEX for tubulin affords specific T-rich DNA aptamers. Systematic evolution of ligands by exponeential enrichmentE Fukusaki, T Hasunuma, S Kajiyama, et al.Bioorganic & Medicinal Chemistry Letters|October 26, 2001
The discovery of anthranilic acid-based MMP inhibitors. Part 3: incorporation of basic aminesJ I Levin, J M Chen, M T Du, et al.Bioorganic & Medicinal Chemistry Letters|October 26, 2001
Visualizing antibody-catalyzed retro-aldol-retro-Michael reactionsF Tanaka, L Kerwin, D Kubitz, et al.Bioorganic & Medicinal Chemistry Letters|November 21, 2001
Cellular solid-phase binding assay and mass spectrometry for screening of alpha 4 beta 7 integrin antagonistsD Gottschling, J Boer, A Schuster, et al.Pageof 2,631